Skip to main content
Nature Communications logoLink to Nature Communications
. 2020 May 18;11:2543. doi: 10.1038/s41467-020-16344-z

Author Correction: Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer

Anniina Färkkilä 1,2,3,4, Doga C Gulhan 2,#, Julia Casado 3,#, Connor A Jacobson 4, Huy Nguyen 1, Bose Kochupurakkal 1, Zoltan Maliga 4, Clarence Yapp 4, Yu-An Chen 4, Denis Schapiro 4, Yinghui Zhou 5, Julie R Graham 5, Bruce J Dezube 5, Pamela Munster 6, Sandro Santagata 7, Elizabeth Garcia 8, Scott Rodig 8, Ana Lako 8, Dipanjan Chowdhury 1, Geoffrey I Shapiro 1, Ursula A Matulonis 1, Peter J Park 9, Sampsa Hautaniemi 3, Peter K Sorger 4, Elizabeth M Swisher 10, Alan D D’Andrea 1,✉,#, Panagiotis A Konstantinopoulos 1,✉,#
PMCID: PMC7235235  PMID: 32424117

Correction to: Nature Communications 10.1038/s41467-020-15315-8, published online 19 March 2020.

The original version of this Article omitted the following from the Acknowledgements:

This research was also supported by the Ludwig Center at Harvard and U54-CA225088 to Peter Sorger, BioEntrepreneur-Fellowship of the University of Zurich, reference no. BIOEF-17-001 and Early Postdoc Mobility fellowship (no. P2ZHP3_181475) to Denis Schapiro.

The original version of this Article contained errors in the author affiliations.

Peter J. Park was incorrectly associated with Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. The affiliation of Peter J. Park with Department of Biomedical Informatics, Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA was inadvertently omitted. This has now been corrected in both the PDF and HTML versions of the Article.

Contributor Information

Alan D. D’Andrea, Email: Alan_dAndrea@dfci.harvard.edu

Panagiotis A. Konstantinopoulos, Email: Panagiotis_konstantinopoulos@dfci.harvard.edu


Articles from Nature Communications are provided here courtesy of Nature Publishing Group

RESOURCES